Contact
Please use this form to send email to PR contact of this press release:
Teva to share a case study on how Biosimilarity has supported their Biosimilar projects | Biosimilars and Biobetters
TO:
Vinh Trinh
SMi Group
+44 (0) 20 7827 6140